Innovation Initative ABCI2

ABC established the Innovation Initiative (ABCI2), a collaborative program to stimulate private investment in brain-related research, remove regulatory and financial barriers to research, and strengthen the entire R&D system for expedited translation of neuroscience research into life changing therapies and cures. This ABC advocacy effort is comprised of key stakeholders within the brain community, including patient advocacy groups, professional societies, and industry, collaborating to advance policy positions, legislation and regulations that will strengthen for-profit incentives to invest in neuroscience research - positively impacting brain diseases and conditions.

Goals/Objectives

The goals and objectives of the American Brain Coalition Innovation Initiative (ABCI2) are to:

Increase private sector investment in central nervous system (CNS) treatments to reverse the slide caused by companies exiting the space.
Create more push/pull incentives to encourage investment.
Enhance public awareness of the importance of private sector engagement in brain research to improve upon current treatments and cures.
Enable more CNS-related public/private partnerships developing projects and initiatives to advance brain research and commercial development.

'The ABC is grateful to our industry partners who continue to champion translational and clinical neuroscience research; we desire to see their work continue and grow for many years to come.”

- Robin Elliott, ABCI2 Chair

ABCI2 Background

Learn how and why ABCI2 was established, view the ABCI2 Process Summary, and review a number of outside resources articulating the problem.

Patient Engagement with the FDA

Collaborate with the ABC in ensuring a more meaningful range of stakeholders, and the lived experiences of patients and their families, are included in the important conversations and decision-making processes of programming at the FDA.

Public-Private Partnerships

Learn how your organization can create connections and leverage resources, help patients, and gain insights through innovative collaborations with industry.